Abstract
Efficacy and Safety of Daratumumab Combined with All-Trans Retinoic Acid in Relapsed/Refractory Multiple Myeloma; Results of the Phase 1/2 Dara/ATRA Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have